PLOD1 is upregulated in osteosarcoma, gastric, breast, glioma, bladder, pancreatic, and hepatocellular cancers (HCCs), correlating with advanced tumor stages, metastasis, and reduced survival [96,97,98,99]. Here, PLOD1 is linked to hepatocellular carcinoma.